These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1804493)

  • 1. The effect of aerosolized SK&F 104353-Z2 on the bronchoconstrictor effect of leukotriene D4 in asthmatics.
    Joos GF; Kips JC; Pauwels RA; Van der Straeten ME
    Pulm Pharmacol; 1991; 4(1):37-42. PubMed ID: 1804493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.
    Kips JC; Joos GF; De Lepeleire I; Margolskee DJ; Buntinx A; Pauwels RA; Van der Straeten ME
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma.
    Wahedna I; Wisniewski AS; Tattersfield AE
    Br J Clin Pharmacol; 1991 Oct; 32(4):512-5. PubMed ID: 1958449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of inhalation of the leukotriene receptor antagonist, SK&F 104353, on leukotriene C4- and leukotriene E4-induced bronchoconstriction in subjects with asthma.
    Christie PE; Spur BW; Lee TH
    J Allergy Clin Immunol; 1991 Aug; 88(2):193-8. PubMed ID: 1652604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SK&F 104353, a selective leukotriene receptor antagonist, inhibits leukotriene D4- and antigen-induced bronchoconstriction in cynomolgus monkeys.
    Osborn RR; Hay DW; Wasserman MA; Torphy TJ
    Pulm Pharmacol; 1992 Sep; 5(3):153-7. PubMed ID: 1332792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes.
    Torphy TJ; Newton JF; Wasserman MA; Vickery-Clark L; Osborn RR; Bailey LS; Yodis LA; Underwood DC; Hay DW
    J Pharmacol Exp Ther; 1989 May; 249(2):430-7. PubMed ID: 2542530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man.
    Spencer DA; Evans JM; Green SE; Piper PJ; Costello JF
    Thorax; 1991 Jun; 46(6):441-5. PubMed ID: 1858084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.
    Smith LJ; Geller S; Ebright L; Glass M; Thyrum PT
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):988-92. PubMed ID: 2158260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of leukotriene D4 inhalation challenge in asthmatics. Effect of a novel leukotriene D4/E4-antagonist (SR 2640) on leukotriene D4-induced bronchoconstriction.
    Frølund L; Madsen F; Nielsen J
    Allergy; 1991 Jul; 46(5):355-61. PubMed ID: 1928658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related antagonism of leukotriene D4-induced bronchoconstriction by p.o. administration of LY-171883 in nonasthmatic subjects.
    Phillips GD; Rafferty P; Robinson C; Holgate ST
    J Pharmacol Exp Ther; 1988 Aug; 246(2):732-8. PubMed ID: 3404455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast causes prolonged, potent leukotriene D4-receptor antagonism in the airways of patients with asthma.
    De Lepeleire I; Reiss TF; Rochette F; Botto A; Zhang J; Kundu S; Decramer M
    Clin Pharmacol Ther; 1997 Jan; 61(1):83-92. PubMed ID: 9024176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma.
    Christie PE; Smith CM; Lee TH
    Am Rev Respir Dis; 1991 Oct; 144(4):957-8. PubMed ID: 1928974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pranlukast, an oral leukotriene receptor antagonist, on leukotriene D4 (LTD4) challenge in normal volunteers.
    O'Shaughnessy TC; Georgiou P; Howland K; Dennis M; Compton CH; Barnes NC
    Thorax; 1997 Jun; 52(6):519-22. PubMed ID: 9227717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of leukotriene D4-induced bronchoconstriction in normal subject.
    Smith LJ; Kern R; Patterson R; Krell RD; Bernstein PR
    J Allergy Clin Immunol; 1987 Sep; 80(3 Pt 1):340-7. PubMed ID: 3624684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the airway response to inhaled leukotriene D4 in normal subjects.
    Kern R; Smith LJ; Patterson R; Krell RD; Bernstein PR
    Am Rev Respir Dis; 1986 Jun; 133(6):1127-32. PubMed ID: 3521417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SK&F S-106203 inhibits leukotriene C4, leukotriene D4 and leukotriene E4 vasopressor responses in the conscious rat.
    Smith EF; Slivjak MJ; Egan JW; Eckardt RD; Newton JF
    Br J Pharmacol; 1990 Jun; 100(2):195-200. PubMed ID: 2165834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single dose of zafirlukast reduces LTD4-induced bronchoconstriction in patients on maintenance inhaled corticosteroid therapy.
    Smith LJ; Hanby LA; Lavins BJ; Simonson SG
    Ann Allergy Asthma Immunol; 1998 Jul; 81(1):43-9. PubMed ID: 9690572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of verapamil and sodium cromoglycate on leukotriene D4 induced bronchoconstriction in patients with asthma.
    Roberts JA; Rodger IW; Thomson NC
    Thorax; 1986 Oct; 41(10):753-8. PubMed ID: 3097863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo.
    Robuschi M; Riva E; Fuccella LM; Vida E; Barnabe R; Rossi M; Gambaro G; Spagnotto S; Bianco S
    Am Rev Respir Dis; 1992 Jun; 145(6):1285-8. PubMed ID: 1595992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of inhaled lysine acetylsalicylate (L-ASA) on bradykinin-induced bronchoconstriction in asthmatics: evidence of contribution of prostaglandins.
    Polosa R; Milazzo VL; Magrì S; Pagano C; Paolino G; Santonocito G; Prosperini G; Crimi N
    Eur Respir J; 1997 Apr; 10(4):866-71. PubMed ID: 9150326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.